XML 48 R37.htm IDEA: XBRL DOCUMENT v3.25.3

Segments and Disaggregated Revenue (Tables)

9 Months Ended

Sep. 30, 2025

Segments and Disaggregated Revenue [Abstract]

Schedule of Segments

Information for the Company’s segments, as well as for Corporate and support, is provided in the following table:

		Construction				Medical				Corporate and support				Oil and Gas				Consolidated
Three Months Ended September 30, 2025
Revenue		$	820,883			$	—			$	—				230,282			$	1,051,165
Significant segment expenses:
Costs of revenue:
Direct labor			132,669				—				—				37,365				170,034
Materials			14,553				—				—				—				14,553
Allocated overhead			882,212				—				—				234,006				1,116,218
Other costs of revenue			58,532				—				—				—				58,532
			1,087,966				—				—				271,371				1,359,337
Operating expenses:
Payroll and related			17,921				—				534,257				216,879				769,057
Professional fees			—				—				1,090,787				306,930				1,397,717
Other expenses			(31,412	)			—				(64,085	)			128,277				32,780
			(13,491	)			—				1,560,959				652,086				2,199,554
Operating loss			(253,592	)			—				(1,560,959	)			(693,175	)			(2,507,726	)
Other income (expense)			267,215				—				(3,009,884	)			(65,477	)			(2,808,146	)
Net loss		$	13,623			$				$	(4,570,843)			$	(758,652	)		$	(5,315,872	)
Total assets		$	5,128,452			$	1,406			$	24,377,206				24,598,614			$	54,105,678
Depreciation and amortization		$	44,715			$	—			$	713				74,292			$	119,720

		Construction				Medical				Corporate and support				Consolidated
Three Months Ended September 30, 2024
Revenue		$	1,753,223			$	—			$	—			$	1,753,223
Significant segment expenses:
Cost of revenue
Direct Labor			194,674				—				—				194,674
Materials			591,353				—				—				591,353
Allocated overhead			1,092,772				—				—				1,092,772
Other costs of revenue							—				—
			1,878,799				—				—				1,878,799
Operating expenses:
Payroll and related			—				—				1,761,827				1,761,827
Professional fees			—				—				275,156				275,156
Other expenses			21,842				10,012				46,672				78,526
			21,842				10,012				2,083,655				2,115,509
Operating income (loss)			(147,418	)			(10,012	)			(2,083,655	)			(2,241,085	)
Other expense			(87,413	)			—				(1,387,607	)			(1,475,020	)
Net loss		$	(234,831	)		$	(10,012	)		$	(3,471,262	)		$	(3,716,105	)
Total assets		$	5,778,540			$	1,406			$	4,019,315			$	9,799,261
Depreciation and amortization		$	113,256			$	—			$	1,830			$	115,086
Capital expenditures			1,136												1,136

		Construction				Medical				Corporate and support				Oil and gas				Consolidated
Nine Months Ended September 30, 2025
Revenue		$	1,840,520			$	—			$	—				498,350			$	2,338,870
Significant segment expenses:
Costs of revenue:
Direct labor			525,092				—				—				87,365				612,457
Materials			597,573				—				—				7,529				605,102
Allocated overhead			2,018,499				—				—				474,999				2,493,498
Other costs of revenue			211,695				—				—				42,513				254,208
			3,352,859				—				—				612,406				3,965,265
Operating expenses:
Payroll and related			68,234				—				1,389,450				604,905				2,062,589
Professional fees			—				—				2,910,225				1,237,682				4,147,907
Other expenses			(19,410	)			967				(4,109	)			213,149				190,597
			48,824				967				4,295,566				2,055,736				6,401,093
Operating loss			(1,561,163	)			(967	)			(4,295,566	)			(2,169,792	)			(8,027,488	)
Other income (expense)			3,184				—				(4,234,398	)			(377,707	)			(4,608,922	)
Net loss		$	(1,557,979	)		$	(967	)		$	(8,529,965	)			(2,547,499	)		$	(12,636,410	)
Total assets		$	5,128,452			$	1,406			$	24,377,206			$	24,598,614			$	54,105,678
Depreciation and amortization		$	148,406			$	—			$	1,984				368,173			$	518,563
Capital expenditure			—				—				—				—				—

		Construction				Medical				Corporate and support				Consolidated
Nine Months Ended September 30, 2024
Revenue		$	3,932,592			$	—			$	—			$	3,932,592
Significant segment expenses:
Costs of revenue:
Direct labor			143,698				—				—				143,698
Materials			820,818				—				—				820,818
Allocated overhead			2,653,515				—				—				2,653,515
Other costs of revenue			-				—				—				-
			3,618,031				—				—				3,618,031
Operating expenses:
Payroll and related			—				—				3,507,118				3,507,118
Professional fees			—				—				1,237,944				1,237,944
Other expenses			113,656				95,972				381,798				591,426
			113,656				95,972				5,126,860				5,336,488
Operating income (loss)			200,905				(95,972	)			(5,126,860	)			(5,021,927	)
Other expense			(275,321	)			—				(7,843,826	)			(8,119,147
Income (loss) before income taxes			(74,416				(95,972	)			(12,970,686	)			(13,141,074	)
Common stock deemed dividend			—				—				(1,638,149	)			(1,638,149	)
Income from discontinued operations			—				—				2,684,678				2,684,678
Net income (loss) attributable to common stockholders		$	(74,416	)		$	(95,972	)		$	(11,924,157	)		$	(12,094,545	)
Total assets		$	5,778,540			$	1,406			$	4,019,315			$	9,799,261
Depreciation and amortization		$	194,803			$	—			$	5,317			$	200,120
Capital expenditure			8,007				—				-				8,007

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration